Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 29681 - 29700 of 44487
HSR Informal Interpretations

0302004 Informal Interpretation

… 0302004 Informal Interpretation 0302004 Informal Interpretation February 12, … Mike: Re: Local Marketing Agreement This letter confirms the advice you communicated to me in our telephone … (Redacted) a Delaware limited liability company (A), is the owner/licensee of a television station located in …
Date
Rule
801.2
Agree. This is not reportable. N. Ovuka and J. Sidorov concur. 2/12/03
Early Termination Notices

20030343: Level 3 Communications, Inc.; Carl C. Icahn

… 20030343: Level 3 Communications, Inc.; Carl C. Icahn HSR Early Termination Notice 20030343: Level 3 Communications, Inc.; Carl C. Icahn 20030343 XO Communications, Inc. Carl C. …
Date
Acquiring Party
Level 3 Communications, Inc.
Acquired Party
Carl C. Icahn
Acquired Entities
XO Communications, Inc.
Early Termination Notices

20030280: Verizon Communications Inc.; Cablevision Systems Corporation

… 20030280: Verizon Communications Inc.; Cablevision Systems Corporation HSR Early Termination Notice 20030280: Verizon Communications Inc.; Cablevision Systems Corporation 20030280 Boston …
Date
Acquiring Party
Verizon Communications Inc.
Acquired Party
Cablevision Systems Corporation
Acquired Entities
Boston Holding, LLC
New York PCS Holding, LLC
Northcoast Communications, L.L.C.
HSR Informal Interpretations

0302003 Informal Interpretation

… 0302003 Informal Interpretation 0302003 Informal Interpretation TO: … with Melea Greenfeld, who I understand no longer works in the Federal Trade Commission's Premerger Notification … might be reportable. I am not sure, though, how to handle to transactions involving facilities operated by the …
Date
Rule
802.5
Advised writer that not enough information is provided to ascertain control of LLCs. In any case, transaction is exempt under 802.5. 2/10/03 M. Verne concurs.
Cases and Proceedings

Baxter International Inc., and Wyeth, In the Matter of

Baxter settled Commission concerns stemming from its $316 million proposed acquisition of Wyeth Corporation's generic injectable drug business and agreed to divest several pharmaceutical products. The Commission charged that the acquisition would reduce competition in the manufacture and sale of propofol (a general anesthetic); new injectable iron replacement therapies; metocloprarnide (used to treat nausea); and vecuronium and pancuronium (neuromuscular blocking agents used to temporarily freeze muscles during surgery). The consent order requires divestitures in each of the pharmaceutical markets.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0210171
Docket Number
C-4068
Advisory Opinions

Opinion 03-1

… Opinion 03-1 Opinion 03-1 Discusses whether a franchisor must disclose a guilty plea involving a violation of the Ontario Gaming Control Act under section 436.1(a)(4) of …
Date
Discusses whether a franchisor must disclose a guilty plea involving a violation of the Ontario Gaming Control Act under section 436.1(a)(4) of the Franchise Rule.
Advisory Opinions

PriMed Physicians

… group practice with 55 physician employees located in Dayton, Ohio, to create with other Dayton-area physicians an advocacy group to undertake "a campaign to inform and educate the general public" about, in the …
Date
re: proposal of PriMed Physicians, a physician group practice with 55 physician employees located in Dayton, Ohio, to create with other Dayton-area physicians an advocacy group to undertake "a...
Displaying 29681 - 29700 of 44487
Return to top